BRONCHIOLITIS OBLITERANS
Clinical trials for BRONCHIOLITIS OBLITERANS explained in plain language.
Never miss a new study
Get alerted when new BRONCHIOLITIS OBLITERANS trials appear
Sign up with your email to follow new studies for BRONCHIOLITIS OBLITERANS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for lung damage after transplant: experimental drug shows promise
Disease control Recruiting nowThis study tests a new drug called belumosudil for people who develop a serious lung condition (bronchiolitis obliterans syndrome) after a stem cell transplant. The goal is to see if the drug can improve lung function or slow the disease. About 45 adults with new or early-stage l…
Matched conditions: BRONCHIOLITIS OBLITERANS
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 05, 2026 11:53 UTC
-
Tiny lung cells may hold key to early detection of deadly transplant complication
Knowledge-focused Recruiting nowThis study looks at abnormal cells in the lungs of people who have bronchiolitis obliterans syndrome after a stem cell or lung transplant. Researchers want to learn more about these cells to help doctors spot the condition earlier in future patients. About 15 participants will ha…
Matched conditions: BRONCHIOLITIS OBLITERANS
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 04, 2026 16:19 UTC